Primary Aldosteronism and Cerebrovascular Diseases

다국어 초록 (Multilingual Abstract)

As diagnostic techniques have advanced, primary aldosteronism (PA) has emerged as the most common cause of secondary hypertension. The excess of aldosterone caused by PA resulted in not only cardiovascular complications, including coronary artery disease,myocardial infarction, arrhythmia, and heart failure, but also cerebrovascular complications, such as stroke and transient ischemicattack. Moreover, PA is associated more closely with these conditions than is essential hypertension. In this review, we present up-todate findings on the association between PA and cerebrovascular diseases.

참고문헌 (Reference)

1 Hayashi R, "saline infusion test highly associated with the incidence of cardio-and cerebrovascular events in primary aldosteronism" 64 : 507-513, 2017

2 Briet M, "Vascular actions of aldosterone" 50 : 89-99, 2013

3 Liao CW, "Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy : prospective study of 102 patients" 6 : 20862-, 2016

4 Harris S, "The association of carotid intima-media thickness(cIMT)and stroke : a cross sectional study" 1 : 164-166, 2012

5 Kasal DA, "T regulatory lymphocytes prevent aldosterone-induced vascular injury" 59 : 324-330, 2012

6 Feigin VL, "Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century" 2 : 43-53, 2003

7 Rocha R, "Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart" 143 : 4828-4836, 2002

8 Kao CC, "Risk of ischemic stroke in primary aldosteronism patients" 438 : 86-89, 2015

9 Miyaji Y, "Primary aldosteronism in patients with acute stroke : prevalence and diagnosis during initial hospitalization" 16 : 177-, 2016

10 Mattsson C, "Primary aldosteronism : diagnostic and treatment strategies" 2 : 198-208, 2006

11 Gyamlani G, "Primary aldosteronism : diagnosis and management" 352 : 391-398, 2016

12 Benetos A, "Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats" 17 : 1152-1156, 1997

13 Ohno Y, "Prevalence of cardiovascular disease and its risk factors in primary aldosteronism : a multicenter Study in Japan" 71 : 530-537, 2018

14 Rossi GP, "Prevalence and diagnosis of primary aldosteronism" 12 : 342-348, 2010

15 Monticone S, "Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice" 69 : 1811-1820, 2017

16 Murata M, "Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism" 35 : 1079-1085, 2017

17 Renna NF, "Pathophysiology of vascular remodeling in hypertension" 2013 : 808353-, 2013

18 Rocha R, "Pathophysiological effects of aldosterone in cardiovascular tissues" 12 : 308-314, 2001

19 Rossi GP, "Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism" 62 : 62-69, 2013

20 Mulatero P, "Long-term cardio-and cerebrovascular events in patients with primary aldosteronism" 98 : 4826-4833, 2013

21 Litchfield WR, "Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism" 31 (31): 445-450, 1998

22 Strauch B, "Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension" 19 : 909-914, 2006

23 Hundemer GL, "Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism" 3 : 768-774, 2018

24 Feigin VL, "Global burden of stroke" 120 : 439-448, 2017

25 Milliez P, "Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism" 45 : 1243-1248, 2005

26 Brown NJ, "Eplerenone : cardiovascular protection" 107 : 2512-2518, 2003

27 Vilela LAP, "Diagnosis and management of primary aldosteronism" 61 : 305-312, 2017

28 Porodko M, "Conn’s syndrome and atrial fibrillation" 357 : 1293-1294, 2001

29 Touboul PJ, "Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk" 36 : 1741-1745, 2005

30 Catena C, "Cardiovascular outcomes in patients with primary aldosteronism after treatment" 168 : 80-85, 2008

31 Monticone S, "Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension : a systematic review and meta-analysis" 6 : 41-50, 2018

32 Savard S, "Cardiovascular complications associated with primary aldosteronism : a controlled cross-sectional study" 62 : 331-336, 2013

33 Nakano S, "Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats" 28 : 925-936, 2005

34 Hundemer GL, "Cardiometabolic outcomes and mortality in medically treated primary aldosteronism : a retrospective cohort study" 6 : 51-59, 2018

35 Bjorck S, "Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study" 44 : 3103-3108, 2013

36 Watson T, "Atrial fibrillation in primary aldosteronism" 10 : 190-194, 2009

37 Al-Aloul B, "Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism(Conn’s syndrome)" 29 : 1303-1305, 2006

38 Wolf PA, "Atrial fibrillation as an independent risk factor for stroke : the Framingham Study" 22 : 983-988, 1991

39 Bernini G, "Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism" 26 : 2399-2405, 2008

40 Mattace-Raso FU, "Arterial stiffness and risk of coronary heart disease and stroke : the Rotterdam Study" 113 : 657-663, 2006

41 Blacher J, "Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients" 33 : 1111-1117, 1999

42 Satoh M, "Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake : the Ohasama study" 25 : 777-783, 2012

43 Calo LA, "Aldosterone-mediated endothelial remodeling and oxidative stress" 68 : 1899-, 2005

44 Mazak I, "Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells" 109 : 2792-2800, 2004

45 Rossi GP, "Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term" 71 : 585-591, 2018

46 Lin YH, "Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma" 221 : 154-159, 2012

47 Strauch B, "Adrenalectomy improves arterial stiffness in primary aldosteronism" 21 : 1086-1092, 2008